These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 7513854

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Inadequate therapies with implantable cardioverter-defibrillators--incidence, etiology, predictive factors and preventive strategies].
    Weber M, Block M, Brunn J, Bänsch D, Böcker D, Hammel D, Gietzen F, Breithardt G.
    Z Kardiol; 1996 Nov; 85(11):809-19. PubMed ID: 9064943
    [Abstract] [Full Text] [Related]

  • 3. Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators.
    Grimm W, Flores BF, Marchlinski FE.
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 1):1667-73. PubMed ID: 1279533
    [Abstract] [Full Text] [Related]

  • 4. The value of rate regularity and multiplicity measures to detect ventricular tachycardia in the presence of atrial fibrillation or flutter.
    Chiang CM, Jenkins JM, DiCarlo LA.
    Pacing Clin Electrophysiol; 1994 Sep; 17(9):1503-8. PubMed ID: 7991421
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M, Brachmann J, Block M, Siebels J, Hoffmann E, Almendral J, Ohm OJ, den Dulk K, Coumel P, Camm AJ.
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [Abstract] [Full Text] [Related]

  • 6. Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients?
    Stein KM, Euler DE, Mehra R, Seidl K, Slotwiner DJ, Mittal S, Markowitz SM, Lerman BB, Jewel AF Worldwide Investigators.
    J Am Coll Cardiol; 2002 Jul 17; 40(2):335-40. PubMed ID: 12106941
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias.
    Ricci R, Pignalberi C, Disertori M, Capucci A, Padeletti L, Botto G, Toscano S, Miraglia F, Grammatico A, Santini M.
    Eur Heart J; 2002 Sep 17; 23(18):1471-9. PubMed ID: 12208228
    [Abstract] [Full Text] [Related]

  • 8. Dual chamber implantable cardioverter defibrillator benefits and limitations.
    Fan K, Lee K, Lau CP.
    J Interv Card Electrophysiol; 1999 Oct 17; 3(3):239-45. PubMed ID: 10490480
    [Abstract] [Full Text] [Related]

  • 9. Implantable transvenous cardioverter-defibrillators.
    Bardy GH, Hofer B, Johnson G, Kudenchuk PJ, Poole JE, Dolack GL, Gleva M, Mitchell R, Kelso D.
    Circulation; 1993 Apr 17; 87(4):1152-68. PubMed ID: 8462144
    [Abstract] [Full Text] [Related]

  • 10. Combined third-generation implantable cardioverter defibrillator with permanent unipolar pacemakers: preliminary observations.
    Haffajee C, Casavant D, Desai P, Moon R, Voukydis P, Pacetti P.
    Pacing Clin Electrophysiol; 1996 Feb 17; 19(2):136-42. PubMed ID: 8834682
    [Abstract] [Full Text] [Related]

  • 11. The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients.
    Fischer A, Ousdigian KT, Johnson JW, Gillberg JM, Wilkoff BL.
    Heart Rhythm; 2012 Jan 17; 9(1):24-31. PubMed ID: 21835150
    [Abstract] [Full Text] [Related]

  • 12. Holter documented sudden death in a patient with an implanted defibrillator.
    Birgersdotter-Green U, Rosenqvist M, Lindemans FW, Rydén L, Rådegran K.
    Pacing Clin Electrophysiol; 1992 Jul 17; 15(7):1008-14. PubMed ID: 1378592
    [Abstract] [Full Text] [Related]

  • 13. Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice.
    Jodko Ł, Kornacewicz-Jach Z, Kaźmierczak J, Rzeuski R, Zielonka J, Kaliszczak R, Safranow K.
    Cardiol J; 2009 Jul 17; 16(5):432-9. PubMed ID: 19753522
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Importance of abortive shock capability with electrogram storage in cardioverter-defibrillator devices.
    Hurwitz JL, Hook BG, Flores BT, Marchlinski FE.
    J Am Coll Cardiol; 1993 Mar 15; 21(4):895-900. PubMed ID: 8450157
    [Abstract] [Full Text] [Related]

  • 17. [Inadequate therapeutic effects of implantable cardioverter/defibrillators: etiology, therapy and prevention].
    Mattke S, Dorwarth U, Müller D, Hoffmann E, Markewitz A, Kaulbach H, Schmöckel M, Steinbeck G.
    Z Kardiol; 1994 May 15; 83(5):359-65. PubMed ID: 8053245
    [Abstract] [Full Text] [Related]

  • 18. Clinical experience with antitachycardia pacing and improved detection algorithms in a new implantable cardioverter-defibrillator.
    Wietholt D, Block M, Isbruch F, Böcker D, Borggrefe M, Shenasa M, Breithardt G.
    J Am Coll Cardiol; 1993 Mar 15; 21(4):885-94. PubMed ID: 8185728
    [Abstract] [Full Text] [Related]

  • 19. Limitations and late complications of third-generation automatic cardioverter-defibrillators.
    Nunain SO, Roelke M, Trouton T, Osswald S, Kim YH, Sosa-Suarez G, Brooks DR, McGovern B, Guy M, Torchiana DF.
    Circulation; 1995 Apr 15; 91(8):2204-13. PubMed ID: 7697850
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.